Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Buy
62,846
+13,421
+27% +$2.44M 3.58% 8
2026
Q1
$9.37M Sell
49,425
-1,842
-4% -$392K 3.44% 15
2025
Q4
$11.7M Sell
51,267
-1,387
-3% -$305K 5.05% 5
2025
Q3
$10.4M Buy
+52,654
New +$10.5M 4.59% 10

Other funds holding DHR

Spinecap SAS's DHR Position: Q2 2026 in Review

Spinecap SAS increased its Danaher (DHR) stake by 27% in Q2 2026, buying an estimated $2.44M and bringing the position to 62,846 shares worth $12M. The position accounts for 3.58% of the portfolio, ranked #8.

Spinecap SAS first reported a position in DHR in Q3 2025 and has held it in 4 quarters since. 793 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • Spinecap SAS held 62,846 shares of Danaher worth $12M as of Q2 2026.
  • Spinecap SAS bought 13,421 Danaher shares in Q2 2026, an estimated $2.44M.
  • Danaher made up 3.58% of Spinecap SAS's portfolio in Q2 2026, its #8 holding.
  • Spinecap SAS first reported a position in Danaher in Q3 2025 and has held it in 4 quarters since.
  • 793 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on Spinecap SAS's 13F filing for Q2 2026, filed 27 Jul 2026.